447 related articles for article (PubMed ID: 35371054)
21. Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps.
Wang H; Do DC; Liu J; Wang B; Qu J; Ke X; Luo X; Tang HM; Tang HL; Hu C; Anderson ME; Liu Z; Gao P
J Allergy Clin Immunol; 2018 Feb; 141(2):586-600.e6. PubMed ID: 28689792
[TBL] [Abstract][Full Text] [Related]
22. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of endurance training and nettle leaf extract on the IDO1-KYN-AHR pathway homeostasis and inhibiting of liver toxicity in rats with STZ-induced diabetes.
Haghshenas R; Aftabi Y; Doaei S; Gholamalizadeh M
Front Endocrinol (Lausanne); 2023; 14():1071424. PubMed ID: 37305057
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
Engin AB; Engin A
Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
[TBL] [Abstract][Full Text] [Related]
26. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
Front Immunol; 2021; 12():678999. PubMed ID: 34025677
[TBL] [Abstract][Full Text] [Related]
27. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults.
Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB
Front Immunol; 2022; 13():917966. PubMed ID: 36248784
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
29. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1).
Gonçalves M; Furgiuele A; Rasini E; Legnaro M; Ferrari M; Luini A; Rodrigues-Santos P; Caramelo F; Marino F; Pereira FC; Cosentino M
Eur J Pharmacol; 2024 Apr; 968():176420. PubMed ID: 38367683
[TBL] [Abstract][Full Text] [Related]
30. Kynurenine, a Tryptophan Metabolite That Increases with Age, Induces Muscle Atrophy and Lipid Peroxidation.
Kaiser H; Yu K; Pandya C; Mendhe B; Isales CM; McGee-Lawrence ME; Johnson M; Fulzele S; Hamrick MW
Oxid Med Cell Longev; 2019; 2019():9894238. PubMed ID: 31737181
[TBL] [Abstract][Full Text] [Related]
31. Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia.
Lindström V; Aittoniemi J; Jylhävä J; Eklund C; Hurme M; Paavonen T; Oja SS; Itälä-Remes M; Sinisalo M
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):363-5. PubMed ID: 22981691
[TBL] [Abstract][Full Text] [Related]
32. Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway.
Zhang Y; Tu S; Ji X; Wu J; Meng J; Gao J; Shao X; Shi S; Wang G; Qiu J; Zhang Z; Hua C; Zhang Z; Chen S; Zhang L; Zhu SJ
Nat Commun; 2024 Feb; 15(1):1333. PubMed ID: 38351003
[TBL] [Abstract][Full Text] [Related]
33. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
[TBL] [Abstract][Full Text] [Related]
34. IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.
Öztürk S; Kalter V; Roessner PM; Sunbul M; Seiffert M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920868
[TBL] [Abstract][Full Text] [Related]
35. Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis.
Wu D; Chen M; Chen S; Zhang S; Chen Y; Zhao Q; Xue K; Xue F; Chen X; Zhou M; Li H; Zheng J; Le Y; Cao H
Clin Rheumatol; 2022 Oct; 41(10):3107-3117. PubMed ID: 35778590
[TBL] [Abstract][Full Text] [Related]
36. Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1
Chen F; Zhao D; Huang Y; Wen X; Feng S
Life Sci; 2023 Dec; 335():122239. PubMed ID: 37944638
[TBL] [Abstract][Full Text] [Related]
37. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives.
Peyraud F; Guegan JP; Bodet D; Cousin S; Bessede A; Italiano A
Front Immunol; 2022; 13():807271. PubMed ID: 35173722
[TBL] [Abstract][Full Text] [Related]
38. Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.
Gargaro M; Vacca C; Massari S; Scalisi G; Manni G; Mondanelli G; Mazza EMC; Bicciato S; Pallotta MT; Orabona C; Belladonna ML; Volpi C; Bianchi R; Matino D; Iacono A; Panfili E; Proietti E; Iamandii IM; Cecchetti V; Puccetti P; Tabarrini O; Fallarino F; Grohmann U
Front Immunol; 2019; 10():1973. PubMed ID: 31481962
[TBL] [Abstract][Full Text] [Related]
39. Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Tousif S; Wang Y; Jackson J; Hough KP; Strenkowski JG; Athar M; Thannickal VJ; McCusker RH; Ponnazhagan S; Deshane JS
Front Immunol; 2021; 12():747780. PubMed ID: 34867973
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
Front Immunol; 2021; 12():713989. PubMed ID: 34394118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
